Related references
Note: Only part of the references are listed.Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma
Nusret Yilmaz et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2021)
Management of incidental adrenal masses: an update
Daniel I. Glazer et al.
ABDOMINAL RADIOLOGY (2020)
Serum cortisol level after low dose dexamethasone suppression test may be predictive for diabetes mellitus and hypertension presence in obese patients: A retrospective study
Sema Hepsen et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation
F. Ceccato et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition
Marta Araujo-Castro et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2020)
Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women
Iacopo Chiodini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Marta Araujo-Castro et al.
ENDOCRINE (2019)
Autonomous cortisol secretion in adrenal incidentalomas
Marta Araujo-Castro et al.
ENDOCRINE (2019)
Updates to theStandards of Medical Care in Diabetes—2018
DIABETES CARE (2018)
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks
Valentina Morelli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Pitfalls in the diagnosis and management of Cushing's syndrome
Vivek Bansal et al.
NEUROSURGICAL FOCUS (2015)
Patients With Apparently Nonfunctioning Adrenal Incidentalomas May Be at Increased Cardiovascular Risk Due to Excessive Cortisol Secretion
Ioannis I. Androulakis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Long-Term Follow-Up in Adrenal Incidentalomas: An Italian Multicenter Study
Valentina Morelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
Guido Di Dalmazi et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Incidentalomas - A disease of modern imaging technology
Jennifer Wagner et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study
Guido Di Dalmazi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Increased Risk of Unfavorable Metabolic Outcome during Short-Term Follow-Up in Subjects with Nonfunctioning Adrenal Adenomas
S. Yener et al.
MEDICAL PRINCIPLES AND PRACTICE (2012)
AME Position Statement on adrenal incidentaloma
M. Terzolo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects
V. Morelli et al.
CLINICAL ENDOCRINOLOGY (2010)
Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma
Cristina Eller-Vainicher et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas
R. Giordano et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications
M. Peppa et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
Melpomeni Peppa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
The urinary steroid profile in patients diagnosed with adrenal incidentaloma
Allicja Kotlowska et al.
CLINICAL BIOCHEMISTRY (2009)
Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study
E. Vassilatou et al.
CLINICAL ENDOCRINOLOGY (2009)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN ASSOCIATION OF ENDOCRINE SURGEONS MEDICAL GUIDELINES FOR THE MANAGEMENT OF ADRENAL INCIDENTALOMAS: EXECUTIVE SUMMARY OF RECOMMENDATIONS
Martha A. Zeiger et al.
ENDOCRINE PRACTICE (2009)
Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study
Iacopo Chiodini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus
A. Tabari et al.
ANNALES D ENDOCRINOLOGIE (2008)
Prevalence and natural history of adrenal incidentalomas
L Barzon et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Management of the clinically inapparent adrenal mass (incidentaloma)
MM Grumbach et al.
ANNALS OF INTERNAL MEDICINE (2003)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
SM Grundy et al.
CIRCULATION (2002)
Share Paper
